INVESTIGATORS ARE CENTRAL TO OUR
CLINICAL RESEARCH
At Regeneron, we develop important new medicines for people living with serious diseases. Clinical trials allow us to carefully test and collect data about potential new medicines before they can be approved for use. A few basic principles guide our clinical research:
- We follow the science. We invent and research potential new medicines for a broad range of medical conditions. Most of our approved medicines, as well as 30+ investigational medicines in our pipeline, are primarily “homegrown” therapeutics discovered and developed in our labs and span dozens of diseases. Learn more about our pipeline.
- We listen to learn. We work closely with patient communities to listen and learn about their experiences with specific diseases. We put those insights into action with innovative clinical trial designs, efficient recruitment processes and repeatedly push the bounds of science to deliver potential new medicines to patients.
Visit Regeneron Medical Affairs portal for U.S. healthcare providers
RegeneronMedical.com is an online portal for U.S. healthcare professionals that provides easy access to education and resources. The portal includes disease state education materials, medical information for approved medicines, clinical trial and pipeline information and Regeneron-sponsored publications.
Collaborate with Regeneron on clinical research
What’s your clinical research legacy? Learn more about how to collaborate with Regeneron as an investigator or by enrolling your patients in a clinical trial by contacting our Global Medical Information department. Because legacies aren’t just meant to be left, they’re meant to be lived.
Resources for your patients
Do your patients have questions about clinical trials? Direct them to our FAQs to learn more.
